Evolving role of pharmaceutical physicians in medical evidence and education

Abstract

Sajita Setia,1 Nicola J Ryan,2 Prasad S Nair,3 Elma Ching,3 Kannan Subramaniam4 1Medical Affairs, Pfizer Pte Ltd, Singapore; 2Independent Medical Writing Services, Auckland, New Zealand; 3Department of Pharmacy, National University of Singapore, Singapore; 4Global Medical Affairs, Asia-Pacific Region, Pfizer Australia, West Ryde, NSW, Australia Abstract: The role of pharmaceutical physicians who are the experts working in pharmaceutical companies has progressed over the last few decades, from supervising research and development (R&D) studies and/or providing support to marketing teams to serving an independent critical function. In this review, we focus on pharmaceutical physicians serving medical affairs functions in the pharmaceutical industry. Historically, members of the medical affairs team mainly provided a bridge between commercial teams and the R&D sector and between the organization and external stakeholders. Such teams may even have been managed by other departments, with an emphasis on acquiring and generating data for regulatory purposes. In recent years, the role of medical affairs has broadened due to a change in focus and the increasingly stringent regulatory landscape. Strict regulations require the detachment of commercial from medical activities within pharmaceutical organizations. This change provides an opportunity for a different type of partnership, allowing scientifically minded and medically driven initiatives. This article summarizes the key role of pharmaceutical industry-based physicians in medical affairs and discusses the emerging and evolving role of medical affairs for value creation in evidence generation and medical education. Keywords: medical affairs, medical education, pharmaceutical physicians, pharmaceutical industry

Keywords

• Medical affairs
• Medical education
• Pharmaceutical physicians
• Pharmaceutical industry